Active ingredient
Diatrizoate
7 finished FDA listings contain Diatrizoate as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- DIATRIZOATE MEGLUMINE, DIATRIZOATE SODIUM
- Dosage forms
- Injection, Solution
- Routes
- Intravenous, Intravesical
- Manufacturers / labelers
- 1
- Strengths listed
- 180 mg/ml · 300 mg/ml
- Brand names in FDA listings
- Cystografin, Cystografin Dilute
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 3319
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 010040 | BRACCO | 1955-08-02 | 2 |
Official labeling on DailyMed
- CYSTOGRAFIN (DIATRIZOATE MEGLUMINE) INJECTION, SOLUTION [BRACCO DIAGNOSTICS INC] · version 7 · 2025-12-03
- CYSTOGRAFIN DILUTE (DIATRIZOATE MEGLUMINE) INJECTION, SOLUTION [BRACCO DIAGNOSTICS INC] · version 7 · 2025-12-03
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.